The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Clinical Significance of α II-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury
Abstract
Following traumatic brain injury (TBI), the cytoskeletal protein alpha-II-spectrin is proteolyzed by calpain and caspase-3 to signature breakdown products. To determine whether alpha -II-spectrin proteolysis is a potentially reliable biomarker for TBI in humans, the present study (1) examined levels of spectrin breakdown products (SBDPs) in cerebrospinal fluid (CSF) from adults with severe TBI and (2) examined the relationship between these levels, severity of injury, and clinical outcome. This prospective case control study enrolled 41 patients with severe TBI, defined by a Glasgow Coma Scale (GCS) score of < or =8, who underwent intraventricular intracranial pressure monitoring. Patients without TBI requiring CSF drainage for other medical reasons served as controls. Ventricular CSF was sampled from each patient at 6, 12, 24, 48, 72, 96, and 120 h following TBI and analyzed for SBDPs. Outcome was assessed using the Glasgow Outcome Score (GOS) 6 months after injury. Calpain and caspase-3 mediated SBDP levels in CSF were significantly increased in TBI patients at several time points after injury, compared to control subjects. The time course of calpain mediated SBDP150 and SBDP145 differed from that of caspase-3 mediated SBDP120 during the post-injury period examined. Mean SBDP densitometry values measured early after injury correlated with severity of injury, computed tomography (CT) scan findings, and outcome at 6 months post-injury. Taken together, these results support that alpha -II-spectrin breakdown products are potentially useful biomarker of severe TBI in humans. Our data further suggests that both necrotic/oncotic and apoptotic cell death mechanisms are activated in humans following severe TBI, but with a different time course after injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
WILSON, J. T. L., PETTIGREW, L. E. L., & TEASDALE, G. M. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.573 · Cited by 2,386
Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients
Hukkelhoven, C. W. P. M., Steyerberg, E. W., Rampen, A. J. J., Farace, E., Habbema, J. D. F., Marshall, L. F., Murray, G. D., & Maas, A. I. R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.4.0666 · Cited by 641
Hall, E. D., Sullivan, P. G., Gibson, T. R., Pavel, K. M., Thompson, B. M., & Scheff, S. W. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.252 · Cited by 319
Cited by
Classification of traumatic brain injury for targeted therapies
Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., & Manley, G. T. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0586 · Cited by 1,141
“For example, if the database is to include all severities of brain injury, are the data items which apply to a patient with a GCS of 4 likely to be of interest in a patient with a GCS of 15?”
InfluentialSelf-citationBlennow, K., Brody, D. L., Kochanek, P. M., Levin, H., McKee, A., Ribbers, G. M., Yaffe, K., & Zetterberg, H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.84 · Cited by 634
Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood
Zetterberg, H., Smith, D. H., & Blennow, K. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.9 · Cited by 596
Early prognosis in traumatic brain injury: from prophecies to predictions
Lingsma, H. F., Roozenbeek, B., Steyerberg, E. W., Murray, G. D., & Maas, A. I. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70065-x · Cited by 465
Fluid biomarkers for mild traumatic brain injury and related conditions
Zetterberg, H., & Blennow, K. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.127 · Cited by 320
Metadata
- Authors
- Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K. W., Robertson, C. S., & Hayes, R. L.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2007-02
- Volume
- 24
- Issue
- 2
- Pages
- 354-366
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W1968582210
- Cited by
- 189
- References
- 4
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Significance of α II-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury. https://app.cochat.ai/papers/10.1089/neu.2006.003789
- The paper
- Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K. W., Robertson, C. S., & Hayes, R. L. (2007). Clinical Significance of α II-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury. Journal of Neurotrauma. https://doi.org/10.1089/neu.2006.003789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.